Breast Cancer News and Research

Latest Breast Cancer News and Research

New research on public perceptions about cancer

New research on public perceptions about cancer reveals that 50-year-old ideas still hold sway while many current lifestyle messages are not getting through.

28 Sep 2011

Treatment of CMV infection can inhibit medullablastomas development

Researchers at Karolinska Institutet in Sweden have demonstrated for the first time that it is possible to inhibit the growth of brain tumours by treating the common Cytomegalovirus (CMV). The virus, which is found in a wide range of tumour types, offers a possible route towards controlling tumour growth and reducing the size of the tumour as a complement to conventional cytotoxin-based therapies.

28 Sep 2011

Close link between SF3B1 mutation and specific feature of myelodysplastic syndromes

Geneticists have discovered that a gene involved in the modification of ribonucleic acid (RNA) is mutated in a significant proportion of people with a collection of blood cancers called myelodysplastic syndromes.

27 Sep 2011

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

Banner MD Anderson Cancer Center, a unique collaboration between Banner Health and The University of Texas MD Anderson Cancer Center, opens today, ushering in a new era of unprecedented cancer care in Arizona.

27 Sep 2011

ISRA sponsors 'Susan G. Komen Shoot for the Cure' event

In observance of National Breast Cancer Awareness Month, the ISRA is pleased to announce its sponsorship of the first annual "Susan G. Komen Shoot for the Cure" benefit shooting event.

27 Sep 2011

Researchers identify frequent SF3B1 gene mutation in myelodysplasia

A genomic study of chronic blood cancer - a precursor to leukaemia - has discovered gene mutations that could enable diagnosis using only a blood test, avoiding the need for an invasive and painful bone marrow biopsy.

27 Sep 2011

Eating blueberries may inhibit breast cancer tumor growth

Eating blueberries may inhibit breast cancer tumor growth, according to a recent study by researchers at the City of Hope in Los Angeles that is published in the October 2011 issue of The Journal Of Nutrition and featured in the September issue of Food Nutrition & Science.

27 Sep 2011

Zoledronic acid may extend survival in older breast cancer patients

A drug used to protect bone may extend survival in older breast cancer patients, according to researchers at the Universities of Sheffield and Leeds.

27 Sep 2011

Zoledronic acid may benefit post-menopausal women with breast cancer

A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress.

26 Sep 2011

Ibandronate controls pain in prostate cancer patients with bone metastases

Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented at the 2011 European Multidisciplinary Cancer Congress.

26 Sep 2011

Genentech announces results of trastuzumab emtansine Phase II study on HER2-positive mBC

Genentech, a member of the Roche Group, today announced the results of the Phase II study TDM4450g in people with previously untreated HER2-positive metastatic breast cancer.

26 Sep 2011

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Laurantis Pharma, a privately held biotechnology company based in Finland, today announced that Lymfactin, adenoviral VEGF-C growth factor therapy, was successful in rebuilding lymphatic vessels in pre-clinical animal models.

26 Sep 2011

Researchers devise protein 'switch' that instructs cancer cells to produce their own medication

Johns Hopkins researchers have devised a protein "switch" that instructs cancer cells to produce their own anti-cancer medication.

26 Sep 2011

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.

26 Sep 2011

Komen Foundation grant enables TGen scientists to study triple-negative breast cancer

The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.

26 Sep 2011

Breast cancer drug combination could stop cancer “in its tracks”

The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer “in its tracks”.

26 Sep 2011

Not enough doctors in Australia to follow up on breast cancer cases

Australian women who have undergone surgery for early-stage breast cancer could be monitored afterwards by their GP instead of a hospital clinic, under a federal government project that acknowledges there will not be enough specialist doctors for the coming wave of cancer cases among ageing baby boomers.

26 Sep 2011

Genetic testing for breast and ovarian cancer

Experts from Cancer Treatment Centers of America (CTCA) provide some clues as to who should be using these tests. They explain that women who have been diagnosed with cancer and/or people who have a strong family history of cancer can consider genetic testing. Red flags to consider are anyone in the family who developed cancer at a young age, multiple family members who developed cancer, if a person experienced bilateral cancer (cancer in both breasts), breast and ovarian cancer in the same woman, or cancer appeared where it wasn’t expected (like breast cancer in men)

26 Sep 2011

Combination of chemo and radiotherapy in breast cancer: Trial

Breast cancer patients who are given radiotherapy and chemotherapy at the same time have a lower the risk of their tumors coming back and this should be considered as a new treatment approach across the world, cancer experts said on Sunday.

26 Sep 2011

Drug combo for breast cancer in post-menopausal women shows promise

Combining two drugs in post-menopausal women with a certain type of advanced breast cancer more than doubled the time they lived without their disease getting worse, a new study data showed.

26 Sep 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

New research on public perceptions about cancer

Treatment of CMV infection can inhibit medullablastomas development

Close link between SF3B1 mutation and specific feature of myelodysplastic syndromes

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

ISRA sponsors 'Susan G. Komen Shoot for the Cure' event

Researchers identify frequent SF3B1 gene mutation in myelodysplasia

Eating blueberries may inhibit breast cancer tumor growth

Zoledronic acid may extend survival in older breast cancer patients

Zoledronic acid may benefit post-menopausal women with breast cancer

Ibandronate controls pain in prostate cancer patients with bone metastases

Genentech announces results of trastuzumab emtansine Phase II study on HER2-positive mBC

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Researchers devise protein 'switch' that instructs cancer cells to produce their own medication

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

Komen Foundation grant enables TGen scientists to study triple-negative breast cancer

Breast cancer drug combination could stop cancer “in its tracks”

Not enough doctors in Australia to follow up on breast cancer cases

Genetic testing for breast and ovarian cancer

Combination of chemo and radiotherapy in breast cancer: Trial

Drug combo for breast cancer in post-menopausal women shows promise

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Breast Cancer News and Research

Latest Breast Cancer News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in